The blind-loop syndrome and its variants. Microbiologic aspects of diagnosis and treatment.
D000693:Anaerobiosis; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000302:isolation & purification*; D001431:Bacteriological Techniques; D001765:Blind Loop Syndrome / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D002701:Chloramphenicol / Q000627:therapeutic use; D005243:Feces / Q000032:analysis; D006801:Humans; D007082:Ileum; D007419:Intestinal Secretions / Q000382:microbiology; D007441:Intubation, Gastrointestinal; D007583:Jejunum / Q000382:microbiology; D008055:Lipids / Q000032:analysis; D008286:Malabsorption Syndromes / Q000175:diagnosis / Q000209:etiology; D008826:Microbial Sensitivity Tests; D011512:Proteus Infections / Q000188:drug therapy; D011513:Proteus mirabilis; D012075:Remission, Spontaneous; D012546:Schilling Test; D014994:Xylose / Q000652:urine
D000900:Anti-Bacterial Agents; D008055:Lipids; D002701:Chloramphenicol; D014994:Xylose